New BRAVO Study Publication Reinforces Clinical Benefits of BLC in Reducing Risk of Bladder Cancer Recurrence

Contributed by: PR Newswire

Tags

PHOTOCURE-Study

More Like This

Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024

Clinical data presentations at the European Association of Urology (EAU) 2025 congress highlight the benefits of using Blue Light Cystoscopy in bladder cancer

Bladder Cancer: Upstaging and risk mitigation with Blue Light Cystoscopy in NMIBC featured at ASCO GU 2025

New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy

New Health Economic analysis in France concludes there is insignificant cost difference between White Light and Blue Light Cystoscopy use when applying ccAFU guidelines

European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care

Positive Results for Hexvix Phase III Clinical Trial in China Presented at the SIU 2023 Congress

Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in the U.S.